Carolyn Calfee, MD
Critical Care Medicine · San Francisco, CANPI 1245338649
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,345 of the $15,218 with a category attached, or 81.1%. 5 manufacturers reported payments, led by Merck at 48.7% of the total. Reporting peaked in 2024 at $9,518 and has fallen 81.1% since, to $1,800 in 2025. Among critical care medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $1170.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$7K
- Boehringer Ingelheim International GmbH$2K
- Janssen Research & Development, LLC$2K
- Aero US Inc$2K
- Fisher & Paykel Healthcare Inc$2K
Across 14 payments — averaging $357,169 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$3.2M
- Amgen$1.1M
- Takeda Pharmaceuticals U.S.A., Inc.$653K
What the payments were for
- Consulting fees$12,34581%
- Speaking & faculty fees$1,50010%
- Travel & lodging$1,2518%
- Food & beverage$1211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 8 | $7,418 |
| Boehringer Ingelheim International GmbH | 2 | $2,400 |
| Janssen Research & Development, LLC | 1 | $2,400 |
| Aero US Inc | 1 | $1,500 |
| Fisher & Paykel Healthcare Inc | 1 | $1,500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,218 in reported general payments places this provider in the 95th percentile of 715 critical care medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in San Francisco
- Ivan ChengSan Francisco$162K
- Romain PirracchioSan Francisco$46K
- Christopher BarnettSan Francisco$36K
- Matthieu LegrandSan Francisco$16K
- Yaron GesthalterSan Francisco$14K
- Connor O'BrienSan Francisco$13K
- Mallar BhattacharyaSan Francisco$10K
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.